Call Us: +353 (0) 1 537 3269 - Mail: info@venncro.com Twitter LinkedIn Home About Us About Venn Our Team Our Values Services Feasibility Regulatory Affairs Project Management Clinical Monitoring Biometrics Biostatistics Data Management & Databases Integration ISC/IDMC Services Interactive Response Technology (IRT) Quality Resourcing & Recruitment Investigator Initiated Studies Investors Innovenn News & Events Careers Contact Clinical Research & Resourcing Solutions across Europe Venn Life Sciences is a European Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology, medical device and academic organisations. With dedicated operations in France, Germany, the Netherlands, the UK and Ireland and Europe wide representation – Venn specialises in multi-site cross cultural clinical trials with unique knowledge of local and EU regulations. Over our 25 year history we have built up substantial therapeutic and study experience, contributing to the efficient management of sites, budgets and communication channels with all parties involved. Venn is renowned for its hands-on approach and consistent delivery of high quality work on time and on budget. Project Management Clinical Monitoring Quality Biometrics News & Events 23Sep Venn CEO Tony Richardson interviewed by Proactive Investors Following on from the Interim Results and Kinesis Pharma B.V. Acquisition news on the 22 September, Venn CEO Tony Richardson... Read More → 22Sep Interim Results for 6 months ended 30 June 2015 Venn Life Sciences Holdings Plc (“Venn” or the “Company”) Interim Results for 6 months ended 30 June 2015 Venn Life... Read More → Featured Items Investigator Initiated Studies Read more information on our experience of IIS News & Events Keep up to date with all the latest news from Venn. Click to our news section for more Careers Check out our Careers Page for more on current positions at Venn Life Sciences loading... Venn Life Sciences Home About Us Investors News & Events Careers Contact Services Services Feasibility Regulatory Affairs Project Management Clinical Monitoring Biometrics Interactive Response Technology (IRT) Quality Resourcing & Recruitment Investigator Initiated Studies Venn Life Offices Ireland – Head Office France France Paris Germany Northern Ireland The Netherlands UK News & Events Venn CEO Tony Richardson interviewed by Proactive Investors Interim Results for 6 months ended 30 June 2015 Proposed acquisition of Kinesis Pharma BV for up to €6.5m Placing to raise £3.57m at 22p & Notice of General Meeting Appointment of Co-Broker Notice of Results – Investor Results Presentation © 2015 Venn Life Sciences All Rights Reserved. Contact Us Twitter LinkedIn Back to Top